Shibata Hiroko, Yoshida Hiroyuki, Izutsu Ken-Ichi, Haishima Yuji, Kawanishi Toru, Okuda Haruhiro, Goda Yukihiro
National Institute of Health Sciences, Kamiyoga 1-18-1, Setagaya-ku, Tokyo158-8501, Japan.
National Institute of Health Sciences, Kamiyoga 1-18-1, Setagaya-ku, Tokyo158-8501, Japan.
Int J Pharm. 2015 Nov 30;495(2):827-39. doi: 10.1016/j.ijpharm.2015.09.053. Epub 2015 Sep 26.
We used surface plasmon resonance (SPR) to measure the affinity and kinetics of the interaction between serum proteins and both conventional and PEGylated liposomes. The effect of the interactions on secretory phospholipase A2 (sPLA2)-induced release of a model drug from liposomes was also assessed. SPR analysis of 12 serum proteins revealed that the mode of interaction between serum proteins and liposomes greatly varies depending on the type of protein. For example, albumin bound to liposomes at slower association/dissociation rates with higher affinity and prevented sPLA2-induced drug release from PEGylated liposomes. Conversely, fibronectin bound at faster association/dissociation rates with lower affinity and demonstrated little impact on the drug release. These results indicate that the effect of serum proteins on sPLA2 phospholipid hydrolysis varies with the mode of interaction between proteins and liposomes. Understanding how the proteins interact with liposomes and impact sPLA2 phospholipid hydrolysis should aid the rational design of therapeutic liposomal formulations.
我们使用表面等离子体共振(SPR)来测量血清蛋白与传统脂质体和聚乙二醇化脂质体之间相互作用的亲和力和动力学。还评估了这些相互作用对分泌型磷脂酶A2(sPLA2)诱导的模型药物从脂质体中释放的影响。对12种血清蛋白的SPR分析表明,血清蛋白与脂质体之间的相互作用模式因蛋白类型而异。例如,白蛋白以较慢的结合/解离速率与脂质体结合,亲和力较高,并阻止sPLA2诱导的药物从聚乙二醇化脂质体中释放。相反,纤连蛋白以较快的结合/解离速率与脂质体结合,亲和力较低,对药物释放的影响很小。这些结果表明,血清蛋白对sPLA2磷脂水解的影响随蛋白与脂质体之间的相互作用模式而变化。了解蛋白如何与脂质体相互作用并影响sPLA2磷脂水解,应有助于合理设计治疗性脂质体制剂。